The Global Allogeneic Stem Cell Transplantation Market Growth Accelerated By Rising Adoption Of Alternative Therapies
Allogeneic Stem Cell Transplantation Market |
Allogeneic stem cell
transplantation is a medical procedure that involves transplanting
hematopoietic stem cells from a donor into a patient. It is used to replace
damaged or destroyed bone marrow with healthy bone marrow stem cells. The
advantages of allogeneic stem cell transplantation include ability to treat
fatal and life-threatening diseases like cancer and blood related disorders.
Over the years there has been a substantial need for alternative therapies for
cancer and other chronic diseases. The global Allogeneic Stem Cell
Transplantation Market is estimated to be valued at US$ 3.9 Bn in 2023 and is
expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising number of people
diagnosed with cancers and genetic blood disorders globally has accelerated the
adoption of alternative therapies like allogeneic stem cell transplantation
over the forecast period. The increasing patient awareness regarding benefits
of this transplantation procedure and development of advanced technologies to
improve transplantation outcomes is expected to boost the market growth.
Factors like reduced risks of rejection and graft-versus-host disease with this
procedure compared to other therapies have increased its popularity. Continuous
efforts by key players and research institutes to develop innovative stem cell
based treatment options will contribute towards market expansion during the
forecast years.
Segment Analysis
The global allogeneic stem cell
transplantation market is dominated by the hematologic malignancies sub-segment.
Hematologic malignancies include blood cancers such as leukemia, lymphoma, and
multiple myeloma. According to World Health Organization, every year over 1
million new cases of hematologic malignancies are reported globally. Allogeneic
stem cell transplantation offers improved survival and cure rate for patients
with hematologic malignancies. This has boosted the growth of the hematologic
malignancies sub-segment.
Key Takeaways
The Global
Allogeneic Stem Cell Transplantation Market Size is expected to witness
high growth. The development of novel drugs and rapid adoption of
transplantation procedures globally are fueling market expansion.
Regional analysis:
North America currently holds the
largest share in the allogeneic stem cell transplantation market and is
expected to continue dominating during the forecast period. Higher healthcare
expenditure, well-developed healthcare infrastructure, and increasing
prevalence of leukemia and lymphoma are some key factors attributed to the
dominance of North America. The Asia Pacific region is anticipated to register
the fastest growth rate over the coming years. Growing healthcare
infrastructure, rising awareness about stem cell transplantation, and
increasing disposable income in China and India are projected to drive the Asia
Pacific market.
Key players:
Key players operating in the
allogeneic stem cell transplantation market are Merck & Co., Inc., Eli
Lilly and Company, Bristol-Myers Squibb Company, Astrazeneca Plc., Fresenius
Medical Care AG & CO. KGAA, and F. Hoffmann-la Roche Ltd. (Genentech,
Inc.), among others. These players are focusing on development of innovative
treatment options to gain competitive advantage.
Get More Insights Here
Comments
Post a Comment